8-KThe WireRoutine
Shareholder Vote
Filed May 23, 2018 · 8y ago · Accession 0001157523-18-001180
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗8-K
1
a51810309.htm
CHEMED CORPORATION 8-K
UNITED STATES SECURITIES
AND EXCHANGE COMMISSION Washington,
D.C. 20549
FORM 8-K CURRENT
REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (date of earliest event reported): May
21, 2018
CHEMED CORPORATION (Exact
name of registrant as specified in its charter)
Delaware
1-8351
31-0791746
(State or other
jurisdiction of
incorporation)
(Commission File Number)
(I.R.S. Employer
Identification
Number)
2600 First Financial Center, 255 East 5th Street, Cincinnati, OH
45202
(Address of principal executive offices)
(Zip Code)
Registrant’s
telephone number, including area code:
(513) 762-6690
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see General Instruction A.2 below):
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or Rule
12b-2 of the Securities Exchange Act of 1934. ⃞
If an
emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. ⃞
Page 1 of 3
Item 5.07 Submission of Matters to a Vote of Security Holders
(a)
On May 21, 2018, Chemed Corporation held its annual meeting of
shareholders.
(b)
Shareholders voted on the matters set forth below:
Item 1. Election of Directors. The following directors, who
constitute the entire Board of Directors, were elected at the
meeting by the votes indicated:
Nominee
For
Against
Abstentions
Kevin J. McNamara
14,348,665
123,751
35,814
George J. Walsh III
13,647,465
824,188
36,576
Joel F. Gemunder
13,626,180
843,949
38,101
Patrick P. Grace
13,615,925
856,418
35,886
Thomas C. Hutton
14,064,873
408,250
35,108
Walter L. Krebs
14,205,560
266,437
36,233
Andrea R. Lindell
14,295,480
176,571
36,178
Thomas P. Rice
14,403,335
68,235
36,659
Donald E. Saunders
13,922,303
550,189
35,737
Frank E. Wood
14,209,722
262,165
36,343
Item 2. Approval and Adoption of the 2018 Stock Incentive Plan. The
proposal to approve and adopt the 2018 Stock Incentive Plan was
approved with the following votes:
Voted
Percent of Voted
For
12,411,824
85.55%
Against
2,050,340
14.13%
Abstain
46,066
0.32%
Broker non-votes
808,516
-
Item 3. Ratification of Independent Accountants. The
proposal to ratify the appointment of PricewaterhouseCoopers LLP
by the Audit Committee of the Board of Directors as the company’s
independent accountants for the year ending December 31, 2018, was
approved with the following votes:
Voted
Percent of Voted
For
15,044,270
98.22%
Against
210,843
1.37%
Abstain
61,633
0.40%
Page 2 of 3
Item 4. Executive Compensation. The proposal to approve, on
a non-binding basis, the Company’s executive compensation program,
was approved with the following votes:
Voted
Percent of Voted
For
13,856,628
95.50%
Against
593,654
4.09%
Abstain
57,948
0.40%
Broker non-votes
808,516
-
Item 5. Stockholder Proposal. The proposal to amend the
proxy access bylaw provisions was disapproved with the following
votes:
Voted
Percent of Voted
For
3,805,332
26.22%
Against
10,033,299
69.15%
Abstain
669,599
4.62%
Broker non-votes
808,516
-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CHEMED CORPORATION
Dated:
May 23, 2018
By:
/s/ Michael D. Witzeman
Michael D. Witzeman
Vice President and Controller
Page 3 of 3
-->
Filing details
- Company
- CHEMED CORP
- Ticker
- CHE
- CIK
- 19584
- Form type
- 8-K
- Filing date
- May 23, 2018
- Report date
- May 21, 2018
- Document
- a51810309.htm
- Size
- 41 KB